Technology scouting for intra-tumoural drug delivery

  • Identified novel technological innovations for intra-tumoural injectable formulations

  • Advised on the attractiveness and feasibility of innovative intra-tumoural technologies

  • Compiled market landscape and competitive intelligence on key players and products

  • Analyse the science and technology behind current and emerging intra-tumoural injectable formulations to administer chemical entities for the treatment of cancer
  • Technology intelligence
    • Identifying key technological innovations along with drugs administered in different tumour sites
    • Analysing maturity level of identified technologies
    • Benchmarking each novel technology for clinical attractiveness and adoption feasibility
  • Entity intelligence
    • Identifying key competitors within each indication and patient population
    • Assessing new entrants along with recent collaborations, mergers and/or acquisitions
  • Key differentiator analysis
    • Conducting a detailed comparison of the client’s technology against identified technologies in the pipeline
    • Factoring in the differences for hype-cycle analysis
    • Conducting market sizing and adoption share analysis


  • Identified novel technologies and created bespoke value proposition for cancer patients, considering market positioning and scale
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on